Sage Therapeutics (SAGE) PT Raised to $261 at RBC Capital

November 5, 2018 7:09 AM EST Send to a Friend
RBC Capital analyst Brian Abrahams raised the price target on Sage Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login